Have Long COVID? Newest Booster Vaccines May Help You
SOURCES:
Jackie Dishner, Phoenix.
Ziyad Al-Aly, MD, director, Clinical Epidemiology Center, Washington University, St. Louis; chief of Research and Development Service, Veterans Affairs St. Louis Health Care System.
Nature Medicine: “Acute and postacute sequelae associated with SARS-CoV-2 reinfection.”
The Lancet eClinical Medicine: “Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review.”
The British Medical Journal: “Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.”
Stephen J. Thomas, MD, director, Institute for Global Health and Translational Science, Upstate Medical University, Syracuse, NY.
Cell Death & Differentiation, “Long Covid: where we stand and challenges ahead.”
Scott Roberts, MD, associate medical director, infection prevention, Yale New Haven Hospital, New Haven, CT.
Yale School of Medicine Iwasaki Lab: “Immunology of long COVID.”
FDA: “Covid-19 Bivalent Vaccine Boosters.”
CDC: “Stay Up to Date with COVID-19 Vaccines Including Boosters,” “COVID Data Tracker, COVID in Your Community,” “COVID Data Tracker, COVID-19 Vaccinations in the United States.”
The New England Journal of Medicine: “A Bivalent Omicron-Containing Booster Vaccine against Covid-19.”
bioRxiv: “Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine.”
